ArticleCancer research2008
Interleukin-21 augments the efficacy of T-cell therapy by eliciting concurrent cellular and humoral responses.
Takekazu Iuchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it